Pharmaceutical Technology

NOVEMBER 4, 2022

Amidst this, the UK pharmaceutical industry has its own unique set of issues that a head of state will need to tackle in order to support growth and innovation. For the life sciences and pharmaceutical sector, the Conservative government promised £34 billion ($38.98 Consistent government action needed. This would come from “£16.3

Documentation 93

Documentation Pharmaceutical Companies Pharmaceutical Companies 93

ISPE

MAY 17, 2023

A common reason for this is that digital transformation efforts often fail to successfully move from the boardroom to the plant room, resulting in a disjointed user experience with limited success. Both sectors are heavily regulated and struggle to introduce significant changes due to existing digital tools and complex requirements.

Communication 52

Communication 52

pharmaphorum

MAY 6, 2022

For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated challenge. Closing the digital expectation gap in pharma. Combination pricing: access to the future of oncology treatment. Subscribe to future issues of Deep Dive.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JULY 16, 2021

Debiopharm Innovation Fund’s Tanja Dowe on investing in digital health start-ups and supporting them on their rollercoaster rides to improve patient outcomes. The weight of expectation hangs heavy over the digital health sector. The post Enabling healthcare’s digital future appeared first on.

40

40

pharmaphorum

JULY 8, 2022

A recent Science 37 survey noted that nearly three-quarters (73%) of respondents from the pharma industry were planning a hybrid or DCT, up from 49% in 2021. Significant opportunities exist for pharma to partner with technologists to leverage digital and sensor technologies to drive further time-and cost-efficiencies in clinical trials.

FDA 99

FDA 99

pharmaphorum

APRIL 11, 2022

Dudley Tabakin, CEO of VivoSense, describes how this financing is set to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. We were really searching for the right investment in this emerging digital space. Exploring the wider impact on digital healthcare.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Packaging 110

PharmaShots

FEBRUARY 16, 2023

Suresh Kannan: This latest semi-annual platform update brings innovative revenue optimization and compliance solutions to our high-tech and life sciences customers, including pharmaceutical manufacturers. We’ve aimed our latest product innovations to power customers’ profitability and business growth.

Communication 40

Communication Hospitals 40

pharmaphorum

APRIL 28, 2021

Eric Gilbert explores how data science techniques like text mining are speeding up research into areas such as pancreatic cancer. As a result, many researchers and organisations are relying more on digital technologies and data science techniques to help break down and digest the information available.

Immunization 105

Immunization 105

pharmaphorum

NOVEMBER 25, 2021

Now, as face-to-face engagement returns to the agenda, all eyes are on the future shape of pharma events as the world starts to navigate its way out of pandemic conditions. Rethinking pharma’s events’ strategy. A common first step for digital meetings was often to take what was used to occur face-to-face and put it online.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Communication 98

Communication 98

pharmaphorum

JANUARY 26, 2021

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Well, it goes without saying, COVID-19 has resulted in a rapid adoption of digital technologies across all industries, most notably in healthcare.

Health and Personal Care Stores 141

Health and Personal Care Stores Medication Guidelines Insurance Communication 141

pharmaphorum

OCTOBER 19, 2020

As part of our series of opinion pieces from leaders at Janssen, the company’s Maria Raad looks at how we can embrace tech and data science to overcome increasing pressures on healthcare systems. In the past, our collective adoption of, and trust in, digital technology has been incremental and often reluctant.

Communication 128

Communication Hospitals 128

pharmaphorum

AUGUST 31, 2021

For the innovators and early adopters of the life sciences industry, engineering a regulatory-grade ECA can be daunting. Still, in 2021, we have seen the industry evolve and develop strategies on how to establish a viable ECA. Myth 1: There are too many challenges with adopting an ECA. About the authors.

FDA 89

FDA Insurance Coverage Documentation Insurance 89

ISPE

MAY 10, 2023

Merck supplies over 150 billion doses of life-enhancing medicines and vaccines (human and animal health) to over 140 countries. Sanat holds a master’s degree in industrial engineering and management science from NITIE, Mumbai, and a bachelor’s degree in chemical engineering from Jadavpur University, Kolkata, India.

Vaccines 52

Vaccines 52

pharmaphorum

JULY 1, 2021

Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm’s Tanja Dowe. Chemistry, engineering and computer science will have to play together in a much more integrated way than they have to date.

Pharmaceutical Companies 87

Pharmaceutical Companies Pharmaceutical Companies Patient Care Vaccines 87

pharmaphorum

MAY 18, 2022

While around 70% of epilepsy patients today are well-controlled and largely able to enjoy a ‘normal’ quality of life, either seizure-free or with a much lower frequency of seizures, we are working hard to understand the underlying causes of the symptoms of those remaining 30% who still don’t respond to available therapies,’ explains Charl.

Pharmaceutical Companies 92

Pharmaceutical Companies Pharmaceutical Companies Immunization 92

European Pharmaceutical Review

MARCH 2, 2023

Clinical innovation: using digital solutions to deliver the next wave of medicines Having an agreed model for the data that multiple stakeholders and collaborators can work with is potentially transformational in many ways. In the event of a future pandemic, we would soon see the practical benefits of that improved exchange.

FDA 91

FDA 91

pharmaphorum

MAY 18, 2021

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. Pre-commercial companies need to hit the ground running with their launch strategies to be successful,” says Ian Hale, vice president of commercial content at Veeva. “Pre-commercial

52

52

pharmaphorum

JANUARY 27, 2023

She knows only too well how understanding the importance of patient centricity is crucial to the success of any modern life sciences company – but how has the landscape changed since 2019? “I I still feel that it is very important,” Dr Mullen said. “We’ve And this ethos is true of Boyds, as well. “I

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Vaccines Documentation 110

Viseven

NOVEMBER 30, 2022

Jay Rabheru , Head of Marketing, Agency Services, Life Science and Healthcare,? A recent pandemic has accelerated a bit more, but still, it requires a certain standard from the digital experience. But we see the increasing need for customers to forge an ecosystem of partnerships, innovate at scale, and be a part of the market.

52

52

pharmaphorum

JUNE 8, 2022

A healthcare consulting firm for more than 20 years, Avalere partners with leading life sciences companies, health plans, providers, and investors to bring innovative, data-driven solutions to complex healthcare challenges. . A technology-enabled partnership . We are delighted to welcome the Avalere team to FH.

Communication 52

Communication 52

Pharmaceutical Technology

OCTOBER 5, 2022

Technology is advancing the possibilities of healthcare treatments, from the development of innovative new drugs to freeing up time for doctors thanks to monitoring devices for patients with conditions such as diabetes and high blood pressure. Moreover, it creates an environment for ongoing innovation and evolution of tools and services.”.

Compounding 52

Compounding 52

pharmaphorum

JANUARY 25, 2022

Oskar Möbert, Vice President OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engagement, and increase patient reach. “For example, they might want to talk to a nurse, a patient advocate or a digital influencer. . That’s key.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Patient Care 105

pharmaphorum

JUNE 11, 2021

Both the breakneck speed and scale of this vaccine generation and distribution were remarkable and encouraging for the future development of treatments for various conditions. These trends combine to increase the pace of innovation and the precision of therapies. Treat them as such. About the author.

Vaccines 110

Vaccines HIPAA Immunization 110

Viseven

MAY 15, 2023

With the advent of digital marketing, plenty of new forms of online communication emerged and eventually superseded detailing that turned from the most fundamental method of engagement into one of many. One more slide with a simple feedback form added to the end of an e-detailer can dramatically increase customer experience in the future.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Patient Care 52

pharmaphorum

JANUARY 25, 2021

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development. On the path to better product development.

Communication 124

Communication Patient Care FDA 124

European Pharmaceutical Review

FEBRUARY 21, 2023

“Cannabis is becoming more widely accepted around the world and is being widely researched by many international organisations for medicinal purposes,” acknowledged Dr Jaap Venema, the United States Pharmacopeia (USP)’s Chief Science Officer in September 2022. What are your future predictions for the industry?

Pharmaceutical Companies 131

Pharmaceutical Companies Pharmaceutical Companies Compounding 131

ISPE

JULY 19, 2023

™ Is Gaining Momentum and Driving Innovation Trudy Patterson Wed, 07/19/2023 - 08:17 Online Exclusives July / August 2023 Pharma 4.0™ ™ Is Gaining Momentum and Driving Innovation Thomas ZIMMER, PhD 19 July 2023 The fifth Pharma 4.0™ The digital transformation of Pharma 4.0™ The concept of Industry 4.0

Documentation 98

Documentation FDA Labelling Communication 98

pharmaphorum

DECEMBER 14, 2022

As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. Angelini Ventures isn’t a typical corporate venture capital firm.

105

105

pharmaphorum

OCTOBER 6, 2020

But for many life sciences organisations, these tools are either not yet fully adopted or are not being put to good use within their regulatory functions. The Accenture Technology Vision survey found just one-third of 103 life sciences executives have high confidence in their data and validate it extensively.

Documentation 113

Documentation Communication Labelling Data Entry 113

ISPE

MAY 25, 2023

Digital Transformation is the possibility that digital technologies can facilitate efficiency gains and increased customer satisfaction, but many assume just applying the technology automatically results in those improvements. capabilities, digital maturity, and data integrity by design. All Things Connected… Pharma 4.0™

FDA 96

FDA 96

pharmaphorum

MARCH 30, 2021

Alexion’s senior vice president of its international business talks to Paul Tunnah about the importance of “people-centred and vulnerable” leadership, the surprising impacts of COVID and the promising future for treating patients with rare diseases. . Once you start working in rare disease, you get so inspired by the patients.

Hospitals 110

Hospitals Communication Pharmaceutical Companies Pharmaceutical Companies 110

European Pharmaceutical Review

SEPTEMBER 16, 2022

But how will this drive for resilience shape the future of pharmaceutical supply chains? Moreover, Derron Stark, EY Principal, Strategy and Transactions, revealed that depending on the type of product – small molecule versus biologic – the ability to localise supply and thus the overall supply chain strategy differs.

Packaging 93

Packaging Documentation 93

pharmaphorum

MARCH 31, 2021

Technology has enabled us to broaden the conversation and reach a far wider audience than previously possible,” commented panelist Charlotte Moseley, executive director of client engagement, McCann Health Medical Communications. The ultimate goal of data dissemination is to enable faster implementation into clinical practice.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

pharmaphorum

DECEMBER 15, 2022

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the NHS Innovation and Life Sciences Commission Report launch took place at One Great George Street, Westminster, on 12th December 2022. So, too, is addressing digital health inequalities.

Vaccines 97

Vaccines Hospitals 97

pharmaphorum

FEBRUARY 16, 2021

COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? The innovation they brought, the science they used, and their broad vision shaped a framework that could be delivered immensely. But “digital” alone is not enough.

Health and Personal Care Stores 106

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Immunization 106

pharmaphorum

JULY 9, 2021

As demonstrated throughout COVID, digital health is no longer experimental. Digital technologies are proving their value by allowing for better care, improved adherence and a more connected ecosystem between doctors, patients and pharma. We sat down to talk to the founders about their journey and the future of healthcare.

Hospitals 68

Hospitals Communication Immunization Pharmaceutical Companies 68